Bryant Furlow

Contributing Writer https://www.clinicalpainadvisor.com

Bryant Furlow is a contract medical journalist for the Haymarket Medical Network. He holds a BS in biology (summa cum laude) from the University of New Mexico. He covers radiation oncology, immunotherapy, tumor biology, clinical research and health care policy. Prior to joining Haymarket in 2010, Bryant was a newspaper reporter in New Mexico, where he won awards for public health and investigative journalism. He also reports for The Lancet Oncology news desk.

All articles by Bryant Furlow

Practice Management

Communication With Patients Critical for Improved Quality of Life, Lower Costs

Bryant Furlow

October 13, 2017

Overly aggressive or futile care at the end of a patient’s life is particularly costly, both in dollars and in terms of patients’ quality of life.

Chronic Pain

Collaborative Approach Encouraged for Patients with Pain

Bryant Furlow

September 6, 2014

The treatment goal should not be to “cure” pain but rather to restore function.

Pain Comorbidities

Less Weight Gain with Gabapentin Enacarbil Therapy for DPN

Bryant Furlow

September 6, 2014

Gabapentin enacarbil was associated with lower incidences of peripheral edema and weight gain than pregabalin, according to authors of a multicenter, randomized, placebo-controlled Phase 2 study.

Regulatory Issues

Collaboration Between Clinicians, Law Enforcement Key to Deterring Drug Diversion

Bryant Furlow

September 6, 2014

Fewer than 2% of prescribers behave criminally. But those 2% are responsible for more than 90% of law enforcement activity on prescription drug diversion.

Neuropathic Pain

Neuropathic Pain Has Many Causes

Bryant Furlow

September 5, 2014

Pain producers include, but are not limited to, viral and bacterial causes, as well as aseptic inflammation, pressure due to neoplasm or other structural lesions, and endocrine/metabolic mechanisms.

Mental Illness

Challenging Issues in Treating Patients with Depression and Pain

Bryant Furlow

September 5, 2014

Acute pain is lessened with opioid treatment but depression is associated with reduced response to acute opioid treatment.

Practice Management

Know Thyself First When Addressing the ‘Difficult’ Patient

Bryant Furlow

September 5, 2014

Understanding why some patients can be more “difficult” than others can involve understanding
personality differences.

Treatments

Testing Promising for Personalizing Pain Medicine

Bryant Furlow

September 4, 2014

Pharmacogenomic testing can identify how genetic variations affect drug responses, and help guide treatment strategies for patients suffering from chronic pain.

Psychogenic Pain

Some Psychotherapeutic Techniques May Alleviate Stress, Pain

Bryant Furlow

Debra Hughes, MS

September 3, 2014

Stress and anxiety are critical elements of the human pain response, and these can be quantified not only with functional imaging but simply by measuring sympathetic response.

Next post in Psychogenic Pain